YOUNES BEKKALI,HIDENORI TAKAHASHI,DAVID S. THOMSON,JI WANG,RENEE ZINDELL,HOSSEIN RAZAVI,RAJASHEKHAR BETAGERI,MARIO G. CARDOZO,THOMAS A. GILMORE,CHRISTIAN HANKE JUSTUS JOACHIM HARCKEN,THOMAS M. KIRRANE
申请号：
MYPI 20031036
公开号：
MY163491A
申请日:
2003.03.24
申请国别(地区):
MY
年份:
2017
代理人:
摘要：
COMPOUNDS OF FORMULA (IA) AND FORMULA (IB) WHEREIN R1,R2,R3,R4,R5, AND R6 ARE AS DEFINED HEREIN FOR FORMULA (IA) OR FORMULA (IB), OR A TAUTOMER, PRODRUG, SOLVATE, OR SALT THEREOF PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF MODULATING THE GLOCOCORTICOID RECEPTOR FUNCTION AND METHODS OF TREATING DISEASE-STATES OR CONDITIONS MEDIATED BY THE GLUCOCORTICOID RECEPTOR FUNCTION OR CHARACTERIZED BY INFLAMMATORY, ALLERGIC, OR PROLIFERATIVE PROCESSES IN A PATIENT USING THESE COMPOUNDS.
